Clinical Trials
6 trialsNCT03077451 2025-12-17
Nelfinavir Mesylate in Treating Patients With Kaposi Sarcoma
AIDS Malignancy Consortium
Phase 2 Completed
NCT00003008 2023-06-15
Paclitaxel in Treating Patients With AIDS-Related Kaposi's Sarcoma
Eastern Cooperative Oncology Group
Phase 2 Completed
NCT00915694 2019-04-23
Nelfinavir Mesylate, Radiation Therapy, and Temozolomide in Treating Patients With Glioblastoma Multiforme
Abramson Cancer Center at Penn Medicine
Phase 1 Terminated
NCT02080416 2016-06-10
Nelfinavir for the Treatment of Gammaherpesvirus-Related Tumors
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Phase EARLY_PHASE1 Terminated
NCT00233948 2015-04-01
Nelfinavir Mesylate in Treating Patients With Recurrent, Metastatic, or Unresectable Liposarcoma
City of Hope Medical Center
Phase 1/2 Terminated
NCT00002185 2005-06-24
A Pilot, Open-Label, Phase II, Randomized Study to Determine the Effects of Viracept on the Outcome of Cutaneous and Mucosal KS in AIDS Patients With CD4 <= 500 Cells/mm3
NIH AIDS Clinical Trials Information Service
Phase 2 Completed